Product Program year 2025 Source: CMS Open Payments

Alinity

Device Core Diagnostics

PDI 00380740137366

Open in the dashboard

General payments

$403,919

672 payments

Research payments

$7,900,613

277 payments

Through program year 2025, $403,919 in general payments and $7,900,613 in research payments were reported against Alinity (Core Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $130,502 241
2025 Research $168 2
2024 General $43,553 289
2024 Research $108,230 3
2023 General $154,696 59
2023 Research $6,788,599 259
2022 General $75,168 83
2022 Research $1,003,617 13

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $403,919 672 payments
Top recipients General payments · program year 2025
  1. Jesse Ehrenfeld Anesthesiology · Milwaukee, WI $10,596 8% · 2 payments
  2. Ambarish Pandey Cardiovascular Disease · Dallas, TX $10,134 8% · 7 payments
  3. David McClintock Anatomic Pathology & Clinical Pathology · Ann Arbor, MI $9,096 7% · 2 payments
  4. Stephen Master Clinical Pathology/Laboratory Medicine · Philadelphia, PA $9,096 7% · 2 payments
  5. Andrew Beck Anatomic Pathology · Boston, MA $9,096 7% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $20,974 16% · 4 practitioners
  2. Anatomic Pathology Pathology $18,248 14% · 5 practitioners
  3. Anatomic Pathology & Clinical Pathology Pathology $14,124 11% · 17 practitioners
  4. Clinical Pathology/Laboratory Medicine Pathology $12,256 9% · 4 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $11,636 9% · 3 practitioners

The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $22,513 17% · 102 recipients
  2. Texas $17,737 14% · 9 recipients
  3. Massachusetts $15,256 12% · 4 recipients
  4. Pennsylvania $13,687 10% · 5 recipients
  5. Michigan $13,370 10% · 3 recipients

The top 5 of 25 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

672 general · 277 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record